Holen Sie sich die Stockscreener-App
140.35
5.90%
-8.80
Handel nachbörslich:
140.65
0.30
+0.21%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$149.15
Offen:
$149.23
24-Stunden-Volumen:
16.54M
Relative Volume:
1.49
Marktkapitalisierung:
$176.99B
Einnahmen:
$18.44B
Nettoeinkommen (Verlust:
$5.36B
KGV:
33.75
EPS:
4.1583
Netto-Cashflow:
$5.41B
1W Leistung:
+4.82%
1M Leistung:
+36.33%
6M Leistung:
+125.64%
1J Leistung:
+74.11%
1-Tages-Spanne:
$139.50
$149.36
1-Wochen-Bereich:
$131.94
$153.69
52-Wochen-Spanne:
$56.32
$153.69
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Vergleichen Sie LRCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
140.35 | 188.08B | 18.44B | 5.36B | 5.41B | 4.1583 |
|
ASML
Asml Holding Nv
|
1,002.30 | 404.95B | 34.96B | 10.23B | 10.02B | 26.10 |
|
AMAT
Applied Materials Inc
|
211.56 | 178.38B | 28.61B | 6.83B | 5.82B | 8.3875 |
|
KLAC
Kla Corp
|
1,084.74 | 150.08B | 12.15B | 4.06B | 3.74B | 30.40 |
|
TER
Teradyne Inc
|
140.14 | 23.52B | 2.83B | 469.17M | 568.90M | 2.8828 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Shell Asset Management Co. Raises Holdings in Lam Research Corporation $LRCX - MarketBeat
Deutsche Bank Turns Bullish on Lam Research (LRCX) as Semiconductor Demand Surges - Yahoo Finance
CFM Wealth Partners LLC Sells 2,324 Shares of Lam Research Corporation $LRCX - MarketBeat
Investing On The Cutting Edge: Why Lam Research Is Still A Smart Buy (LRCX) - Seeking Alpha
Confluence Wealth Services Inc. Invests $220,000 in Lam Research Corporation $LRCX - MarketBeat
Lam Research (NASDAQ:LRCX) Sets New 1-Year HighHere's Why - MarketBeat
Lam Research (LRCX) Stock Is Up, What You Need To Know - The Globe and Mail
Here's What to Expect From Lam Research's Next Earnings Report - Yahoo Finance
Glass Wealth Management Co LLC Increases Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Simplicity Wealth LLC Takes Position in Lam Research Corporation $LRCX - MarketBeat
Sava Infond d.o.o. Buys 2,250 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Purchased by LGT Fund Management Co Ltd. - MarketBeat
111 Capital Grows Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Purchased by QRG Capital Management Inc. - MarketBeat
Lam Research Corporation $LRCX Stock Position Reduced by Empirical Financial Services LLC d.b.a. Empirical Wealth Management - MarketBeat
Lam Research (NASDAQ:LRCX) Upgraded at Wall Street Zen - MarketBeat
Lam Research (NASDAQ:LRCX) Nasdaq Index Performance Patterns - Kalkine Media
4 Hot Chip Stocks You Can't Ignore - Benzinga
Earnings Growth & Price Strength Make Lam Research (LRCX) a Stock to Watch - Yahoo Finance
Lam Research Partners with JSR/Inpria to Advance Semiconductor Manufacturing - EE Times India
Mirae Asset Global Investments Co. Ltd. Sells 34,151 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Stock Position Lifted by Pure Financial Advisors LLC - MarketBeat
Lbp Am Sa Increases Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp. Hits New 52-Week High of USD 143.09 - Markets Mojo
Why Tech Rallies In October: 5 Stocks With Strong Seasonal Edge - Benzinga
Lam Research (NASDAQ:LRCX) Upgraded by Hsbc Global Res to Hold Rating - MarketBeat
Warren Street Wealth Advisors LLC Acquires New Position in Lam Research Corporation $LRCX - MarketBeat
Gold Investment Management Ltd. Acquires 5,063 Shares of Lam Research Corporation $LRCX - MarketBeat
Robeco Institutional Asset Management B.V. Purchases 902,231 Shares of Lam Research Corporation $LRCX - MarketBeat
New Wave Wealth Advisors LLC Invests $265,000 in Lam Research Corporation $LRCX - MarketBeat
Truist Financial Corp Grows Stake in Lam Research Corporation $LRCX - MarketBeat
Janney Montgomery Scott LLC Reduces Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research and JSR / Inpria collaborate to advance semiconductor manufacturing - dqindia.com
2 Momentum Stocks to Keep an Eye On and 1 Facing Headwinds - The Globe and Mail
What drives Lam Research Corporation stock priceEx-Dividend Date Alerts & Avoid Market Traps With Pro-Level Warnings - earlytimes.in
Lam Research Corporation Announces September Quarter Financial C - GuruFocus
Lam Research Delivers Strong Results Amid Mixed Opinions from Analysts - Yahoo Finance
Semiconductor Equipment Leader Lam Research Schedules Q3 2025 Financial Results Conference Call - Stock Titan
Lam Research (LRCX) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Why Lam Research (LRCX) is Poised to Beat Earnings Estimates Again - Yahoo Finance
Lam Research Corp (LRCX)'s Winning Formula: Financial Metrics and Competitive Strengths - GuruFocus
Rothschild & Co Redburn Increases Lam Research (NASDAQ:LRCX) Price Target to $140.00 - MarketBeat
Lam Research (NASDAQ:LRCX) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says - MarketBeat
Lam Research Corporation (LRCX) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Bernstein Remains a Buy on Lam Research (LRCX) - The Globe and Mail
Meet the Monster Chip Stock Crushing Nvidia on the Market (Hint: It's Not Broadcom) - The Motley Fool
Lam Research (LRCX) Receives a New Rating from HSBC - The Globe and Mail
Consolidated Portfolio Review Corp Increases Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
What data driven models say about Lam Research Corporation’s futureQuarterly Trade Summary & Verified Momentum Stock Ideas - newser.com
Lam Research (LRCX) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Lam Research Unveils VECTOR TEOS 3D - Yahoo Finance
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):